AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tacromus 0.25 Capsule

Prescription Icon
Prescription Required

Marketer

Zydus Cadila

Salt Composition

Tacrolimus (0.25mg)

Overview Tacromus 0.25 Capsule

Post-transplant, Tacromus 0.25mg capsules, used in conjunction with other medications, suppress the immune system to prevent organ rejection (e.g., liver, kidney, heart). This immunosuppressant's dosage and frequency are tailored to your transplant type, weight, and other medications; adhere strictly to your physician's instructions. Administer on an empty stomach, at least one hour prior to or two hours after eating. Consistent use is crucial for optimal efficacy; discontinuation elevates organ rejection risk. Tacromus 0.25mg capsules carry potential side effects, including exacerbated diabetes and kidney issues (requiring immediate medical attention), tremor, infections, hypertension, headaches, and insomnia. Report persistent or worsening side effects to your doctor. Immunosuppression increases infection susceptibility. Inform your doctor of pre-existing conditions like kidney, liver, or heart disease, diabetes, or hypertension, and all current medications (particularly those for infections, pain, or arthritis) due to potential interactions. Minimize sun and UV exposure, as immunosuppressants raise skin cancer risk. Effective contraception is advised for both men and women. Use during pregnancy or breastfeeding is generally discouraged unless medically essential. Regular medical check-ups, including frequent blood pressure monitoring, are necessary throughout treatment.

Uses of Tacromus 0.25 Capsule

Avoiding graft rejection in recipients of organ transplants

Major Benefits of Tacromus 0.25 Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume Tacromus 0.25 Capsule on an empty stomach.

Common Side effects of Tacromus 0.25 Capsule:

  • High blood pressure
  • Increased glucose level in blood
  • Kidney damage
  • Insomnia (difficulty in sleeping)
  • Tremors
  • Headache
  • Abnormal liver function tests
  • Infection

How to use Tacromus 0.25 Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume Tacromus 0.25 Capsule on an empty stomach.

How Tacromus 0.25 Capsule works:

Following organ transplantation (such as liver, kidney, or heart), Tacromus 0.25mg capsules function as an immunosuppressant medication. Their mechanism involves reducing the body's immune reaction, thereby promoting the acceptance of the transplanted organ.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while taking Tacromus 0.25 Capsule.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Tacromus 0.25 Capsule during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescription. Physician consultation is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Tacromus 0.25 Capsule while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Using Tacromus 0.25 Capsule might cause drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Tacromus 0.25 Capsule cautiously. Dosage modification for Tacromus 0.25 Capsule may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Tacromus 0.25 Capsule cautiously, as dose modification may be necessary. Physician consultation is advised.

What if you forget to take Tacromus 0.25 Capsule :

Should you forget a Tacromus 0.25 Capsule dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Tacromus 0.25 Capsule

LabelValue
Chemical Category Macrolide-Lactam Antibiotics
Developing Habits No.
Type of Therapy Cancer Medications

FAQs on Tacromus 0.25 Capsule

Tacromus 0.25 Capsule is a macrolide antibiotic primarily used post-organ transplant. Its immunosuppressant action helps prevent rejection following kidney, heart, or liver transplantation.
While taking Tacromus 0.25 Capsule, avoid live vaccines like measles, mumps, rubella, BCG, yellow fever, chickenpox, and typhoid vaccines, as well as oral polio vaccine and nasal flu vaccine.
Tacromus 0.25 Capsule should be avoided by individuals with allergies to its components, weakened immune systems, high blood pressure, or kidney failure. Pregnant or breastfeeding women, and those planning to receive live vaccines (such as MMR), should also avoid this medication.
Before starting this treatment, tell your doctor if you're pregnant, have allergies, a chronic infection, high blood sugar, high blood pressure, high potassium levels, or a weakened immune system. Also inform your doctor of any medication history, recent vaccines, or upcoming live vaccines.
Tacromus 0.25 Capsule weakens the immune system, raising your risk of infection and, in some cases, certain cancers such as skin and lymphoma. This medication's immunosuppressant effect reduces your body's ability to fight infections. Consult your doctor before starting this medication, and immediately if you experience any infection symptoms, including fever, chills, sweats, cough, flu-like symptoms, muscle aches, or red, painful, or warm skin areas.
Tacromus 0.25 Capsules are not controlled substances because they lack abuse potential. Controlled substances require authorization from medical professionals due to their potential for misuse.
Tacromus 0.25 Capsule
130